Treatment and management of patients with end-stage liver cirrhosis / 临床肝胆病杂志
Journal of Clinical Hepatology
; (12): 31-35, 2021.
Article
in Zh
| WPRIM
| ID: wpr-862543
Responsible library:
WPRO
ABSTRACT
End-stage liver cirrhosis usually refers to chronic liver failure caused by decompensated liver cirrhosis and brings a heavy burden to human health. Liver transplantation is the most effective treatment, but its clinical application is limited by the shortage of liver source and high cost. Artificial liver support system is often used as bridging therapy to liver transplantation. The development of cell therapy brings new hope to this disease. This article summarizes the etiological treatment of end-stage liver cirrhosis and the management of related complications and introduces the indications and timing for artificial liver support system, cell therapy, and liver transplantation in patients with end-stage liver cirrhosis.
Full text:
1
Index:
WPRIM
Language:
Zh
Journal:
Journal of Clinical Hepatology
Year:
2021
Type:
Article